Selecta Biosciences to Participate at the 20th Annual Needham Healthcare Conference
WATERTOWN, Mass., April 05, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Selecta’s Chief Executive Officer, Carsten Brunn, Ph.D., will participate in a fireside chat and one-on-one investor meetings at the virtual 20th Annual Needham Healthcare Conference to be held April 12-15, 2021.
Details on the presentation can be found below.
Date: Tuesday, April 13
About Selecta Biosciences, Inc.
Seeking a SASE Standard
Navigating the IT & Cybersecurity Skills Gap
WFH 101 with SD-WAN